Company Overview

CardioGenics is dedicated to develop more sensitive diagnostic test products to the IVD market. CardioGenics has started several developmental processes aimed to achieve its objective “to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies”.

CardioGenics’ operating philosophy is that “better diagnosis enhances the healthcare professionals’ ability to provide better patient management which saves lives and reduces healthcare costs”. Fulfilling unmet clinical testing needs is the driving force behind CardioGenics’ innovations.

QL Care Analyzer (“QLCA”), a state-of-the-art proprietary point of care (“POC”) immunoanalyzer.

learn more
Series of immunoassay tests to detect cardiac markers.

learn more
Proprietary method for improving the light collection from paramagnetic beads (“Beads”).

learn more

Stock Info

Information for stock quote is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be delayed.